Histiocytic sarcoma involving lymph nodes: Imaging appearance on Gallium-67 and F-18 FDG PET/CT

Clinical Nuclear Medicine

Volumn 36, Issue 6, 2011, Pages e37-e38

  Makis, William ^a   Ciarallo, Anthony ^b   Derbekyan, Vilma ^b   Lisbona, Robert ^b  

^a Brandon Regional Health Centre   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

FDG; Gallium; Histiocytic sarcoma; Lymph nodes; PET CT

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; GALLIUM;

AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; HISTIOCYTIC SARCOMA; HUMAN; LYMPH NODE; MALE; PATHOLOGY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; SCINTISCANNING;

AGED, 80 AND OVER; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HISTIOCYTIC SARCOMA; HUMANS; LYMPH NODES; MALE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052039322     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3182173979     Document Type: Article

References (13)

1. Vos JA, Abbondanzo SL, Barekman CL, et al. Histiocytic sarcoma: a study of five cases including the histiocyte marker CD163. Mod Pathol. 2005;18: 693-704
2. Jaffe ES, Harris NL, Stein H, et al, eds. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 273-290
3. Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. The WHO committee on histiocytic/reticulum cell proliferations. Reclassification working group of the histiocyte society. Med Pediatr Oncol. 1997;29:157-166
4. Fukunaga M, Kato H. Histiocytic sarcoma associated with idiopathic myelofibrosis. Arch Pathol Lab Med. 2004;128:1167-1170
5. Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28:1133-1144
6. Huang SC, Chang CL, Huang CH, et al. Histiocytic sarcoma-a case with evenly distributed multinucleated giant cells. Pathol Res Pract. 2007;203:683-689
7. Binkovitz LA, Olshefski RS, Adler BH. Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings. Pediatr Radiol. 2003;33:598-602
8. Nakahara T, Suzuki T, Uno K, et al. 18F-FDG positron emission tomographic imaging in Erdheim-Chester disease with skeletal and extra-skeletal involvement. Leuk Lymphoma. 2006;47:935-937
9. Alongi F, Blognesi A, Gajate AM, et al. Inflammatory pseudotumor of mediastinum treated with tomotherapy and monitored with FDG PET/CT: a case report and literature review. Tumori. 2010;96:322-326
10. Yu JQ, Zhuang H, Xiu Y, et al. Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography. Clin Nucl Med. 2004;29:209-210
11. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774-777
12. Rao S, Langston A, Galt JR, et al. Extramedullary acute myeloid leukemia and the use of FDG-PET/CT. Clin Nucl Med. 2009;34:365-366
13. Yaman E, Ozturk B, Erdem O, et al. Histiocytic sarcoma: PET-CT evaluation of a rare entity. Ann Nucl Med. 2008;22:715-717.